New York Court Denies Dismissal in Hair-Relaxer Cancer Suit, Keeping Case Alive

### NY Court Rejects Dismissal in Hair Relaxer Cancer Suit

A New York judge slammed the door on hair product makers’ bid to toss a cancer lawsuit, letting plaintiff Mayra Garcia’s claims advance against Strength of Nature over decades of alleged toxic exposure. This ruling keeps alive a sprawling case tying chemical relaxers to uterine cancer, signaling courts won’t boot product liability suits early. For crypto watchers, it spotlights FDA labeling enforcement as a regulatory hammer—echoing SEC tactics on unregistered tokens.

The saga ignited when Garcia, diagnosed with endometrial cancer in 2022 after using relaxers from the 1970s to 2006, sued L’Oreal giants including Strength of Nature. Defendants moved to dismiss her 273-paragraph complaint, arguing it lacked specifics on products, causation, and their knowledge of risks like endocrine-disrupting chemicals. Judge Mary V. Rosado denied the motion entirely on December 8, 2025, finding the detailed allegations—from product photos to studies linking ingredients to gynecological cancers—met New York’s lenient pre-answer standards. Garcia wins discovery; Strength of Nature must answer within 20 days, facing claims of design defects, failure to warn, negligence, fraud, warranty breaches, and FDCA violations.

In plain terms, courts demand only a plausible story at this stage—no proof required yet. Garcia’s suit alleges relaxers were “unreasonably dangerous,” packed with known carcinogens, marketed as “safe” and “natural” without warnings manufacturers “should have known” about. Discovery now unlocks internal docs, testing data, and expert battles—issues like proximate cause head to summary judgment or trial.

**Crypto-Market Impact Analysis:** This bolsters negligence-per-se claims from FDCA breaches, a blueprint SEC loves for “misbranded” tokens or DeFi yields pitched as risk-free sans disclosures. Expect tighter CFTC/SEC scrutiny on stablecoin issuers and exchanges labeling assets “safe” amid volatility—think Tether’s reserves or Coinbase listings. Decentralization feels the squeeze: pseudonymous protocols can’t dodge if courts pierce veils on “foreseeable” harms, hiking compliance costs for DEXs and eroding trader sentiment in unregulated niches. Token classification risks spike if “natural growth” marketing masks utility tokens as commodities.

Hair product precedent warns crypto builders: omit risks at your peril—regulators are watching, lawsuits will stick.